Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
225,970,109
-
Number of holders
-
1,419
-
Total 13F shares, excl. options
-
213,712,340
-
Shares change
-
-54,987
-
Total reported value, excl. options
-
$97,144,686,967
-
Value change
-
-$43,691,666
-
Put/Call ratio
-
108%
-
Number of buys
-
653
-
Number of sells
-
-579
-
Price
-
$454.24
Significant Holders of Elevance Health, Inc. - Common Stock (ELV) as of Q3 2022
1,561 filings reported holding ELV - Elevance Health, Inc. - Common Stock as of Q3 2022.
Elevance Health, Inc. - Common Stock (ELV) has 1,419 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 213,712,340 shares
of 225,970,109 outstanding shares and own 95% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (21,233,783 shares), BlackRock Inc. (21,049,375 shares), STATE STREET CORP (10,805,624 shares), PRICE T ROWE ASSOCIATES INC /MD/ (10,745,891 shares), WELLINGTON MANAGEMENT GROUP LLP (9,201,038 shares), Capital International Investors (6,670,753 shares), FMR LLC (6,523,219 shares), GEODE CAPITAL MANAGEMENT, LLC (4,206,930 shares), BANK OF AMERICA CORP /DE/ (4,175,142 shares), and BAILLIE GIFFORD & CO (3,974,771 shares).
This table shows the top 1,419 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.